Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CKI for Radiation-induced Oral Mucositis in Head and Neck Cancer
NCT04204382Phase 4Unknown
- Sponsor
- Shanxi Zhendong Pharmaceutical Co., Ltd.
- Start
- Dec 2019
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of compound kushen injection in oral mucositis (OM), sponsored by Shanxi Zhendong Pharmaceutical Co., Ltd.. Status: unknown.
02
Drugs
compound kushen injection
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT04204382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04204382.